Derakhshan Behrad
Insider CIK 1853109 · EWTX Chief Business Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,500 | — | $0 | 22,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 29,426 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 7,500 | — | $0 | 36,926 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,171 | $43.79 | $95.1K | 34,755 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 304 | $44.50 | $13.5K | 34,451 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,475 | $43.70 | $108.2K | 31,826 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 150 | $44.44 | $6.7K | 34,301 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,500 | — | $0 | 22,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,475 | $43.70 | $108.2K | 31,826 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 150 | $44.44 | $6.7K | 34,301 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 304 | $44.50 | $13.5K | 34,451 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,171 | $43.79 | $95.1K | 34,755 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 7,500 | — | $0 | 36,926 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 29,426 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 17,344 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 180,000 | — | $0 | 180,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 26,136 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-08-12 | 2025-08-14 | 2,491 | $13.39 | $33.4K | 23,645 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-05-02 | 2025-05-07 | 1,691 | $16.45 | $27.8K | 20,355 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 22,046 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-02-05 | 2025-02-07 | 10,000 | — | $0 | 92,929 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-02-05 | 2025-02-07 | 10,000 | $30.03 | $300.3K | 16,837 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-02-05 | 2025-02-07 | 10,000 | $1.93 | $19.3K | 26,837 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-09-20 | 2024-09-24 | 42,068 | — | $0 | 102,949 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 42,068 | $29.03 | $1.22M | 15,121 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-09-20 | 2024-09-24 | 42,068 | $1.93 | $81.2K | 57,189 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 138,750 | — | $0 | 138,750 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 23,125 | — | $0 | 23,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-05-02 | 2024-05-03 | 1,718 | $18.91 | $32.5K | 13,422 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 5,209 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 15,140 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-02-09 | 2024-02-09 | 4,800 | — | $0 | 145,017 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-02-09 | 2024-02-09 | 4,800 | $20.04 | $96.2K | 7,020 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-02-09 | 2024-02-09 | 4,800 | $1.93 | $9.3K | 11,820 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-02-08 | 2024-02-09 | 4,600 | — | $0 | 149,817 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-02-08 | 2024-02-09 | 4,600 | $1.93 | $8.9K | 11,620 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-02-08 | 2024-02-09 | 4,600 | $20.01 | $92.0K | 7,020 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-02-07 | 2024-02-09 | 600 | — | $0 | 154,417 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-02-07 | 2024-02-09 | 600 | $1.93 | $1.2K | 7,620 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-02-07 | 2024-02-09 | 600 | $20.00 | $12.0K | 7,020 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2023-08-17 | 2023-08-18 | 220,000 | — | $0 | 220,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2023-05-02 | 2023-05-03 | 1,747 | $8.90 | $15.5K | 7,020 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 10,417 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 8,767 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-08-08 | 2022-08-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-05-01 | 2022-05-03 | 15,625 | — | $0 | 15,625 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2021-08-17 | 2021-08-19 | 140,000 | — | $0 | 140,000 | SEC↗ |